Daniel Barsanow: ETHIZIA vs TachoSil for Hemostasis During Open Liver Surgery
Daniel Barsanow, Senior Physician and Specialist in Visceral Surgery at Klinikum Oldenburg AöR, shared a post on X about a recent article by James V. Guarrera et al., published in HPB, adding:
“Safety and effectiveness of ETHIZIA versus TachoSil for hemostasis during open liver surgery: a randomized controlled multicenter trial – HPB”
Title: Safety and effectiveness of ETHIZIA versus TachoSil for hemostasis during open liver surgery: a randomized controlled multicenter trial
Authors: James V. Guarrera, Navpreet Kaur, Cornelis Verhoef, Ivan Zendejas, Jean Botha, Suomi M.G. Fouraschen, Flavio Paterno, Frank Pianka, Robert J. Porte, Benjamin Samstein, Linda Sher, Jason R. Wellen, Johan C.M.E. Bender, Ingrid Fossan, Stuart J. Head, Johannes H.W. de Wilt, ETHIZIA Open Liver Study Collaborator Group
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 8, 2026, 11:06Houman Khosravani: Stroke and Thrombosis – Bridging Neurology and Hemostasis
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH